A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...

People who visit emergency departments because of hallucinogenic drug use are at a heightened risk of developing ...

Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.

Scientists have known for decades that the classic symptoms of schizophrenia, such as jumping to conclusions or difficulty ...

Researchers have identified a potential diagnostic tool for schizophrenia by measuring brain cell activity between the ...

Two new studies and an accompanying short film have described the experiences of racially minoritized groups with physical and mental health conditions during the pandemic, depicting the inequalities ...

Numerous studies over the years have noted an overlap in some symptoms of ADHD with some symptoms of schizophrenia and a link ...

Cobenfy also contains trospium, which blocks some of the side effects. The most common are nausea, vomiting and indigestion.

Zai Lab (ZLAB) announced positive topline results from the company’s Phase 3 multi-center trial evaluating the safety and efficacy of ...

Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia ... much more research is needed to pinpoint precursors to psychotic symptoms ...

On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...